Suppr超能文献

甲氧氯普胺在健康人群和肾脏疾病患者中的血浆蛋白结合情况。

The plasma protein binding of metoclopramide in health and renal disease.

作者信息

Webb D, Buss D C, Fifield R, Bateman D N, Routledge P A

出版信息

Br J Clin Pharmacol. 1986 Mar;21(3):334-6. doi: 10.1111/j.1365-2125.1986.tb05201.x.

Abstract

The plasma protein binding of metoclopramide was measured after addition of the drug (60 ng ml-1) to plasma from 18 patients with renal disease and 18 age and sex matched healthy individuals. The mean free fraction in renal disease (0.59 range 0.41-0.71) was not significantly different from controls (mean 0.6 range 0.56-0.69). In both groups the binding ratio of metoclopramide was significantly related to plasma alpha 1-acid glycoprotein (AAG) concentration but not to albumin or plasma non-esterified fatty acids concentration. Metoclopramide bound to human serum albumin (HSA) to a limited extent and to human AAG to a greater extent indicating that AAG is the major binding protein for the drug in plasma.

摘要

在向18例肾病患者及18例年龄和性别相匹配的健康个体的血浆中加入药物(60 ng/ml)后,测定了胃复安的血浆蛋白结合率。肾病患者的平均游离分数为0.59(范围0.41 - 0.71),与对照组(平均0.6,范围0.56 - 0.69)无显著差异。在两组中,胃复安的结合率均与血浆α1-酸性糖蛋白(AAG)浓度显著相关,而与白蛋白或血浆非酯化脂肪酸浓度无关。胃复安与人类血清白蛋白(HSA)的结合程度有限,与人类AAG的结合程度更高,这表明AAG是该药物在血浆中的主要结合蛋白。

相似文献

7
Protein binding of nifedipine.
J Pharm Pharmacol. 1986 May;38(5):399-400. doi: 10.1111/j.2042-7158.1986.tb04598.x.
10
Serum binding of indapamide in health and disease: primary role of alpha 1-acid glycoprotein.
J Clin Pharmacol. 1988 May;28(5):458-62. doi: 10.1002/j.1552-4604.1988.tb05760.x.

引用本文的文献

3
The plasma protein binding of basic drugs.碱性药物的血浆蛋白结合情况。
Br J Clin Pharmacol. 1986 Nov;22(5):499-506. doi: 10.1111/j.1365-2125.1986.tb02927.x.
4
Pharmacokinetics of high-dose metoclopramide in cancer patients.
Clin Pharmacokinet. 1986 Nov-Dec;11(6):415-24. doi: 10.2165/00003088-198611060-00001.
5
Population analysis of the pharmacokinetic variability of high-dose metoclopramide in cancer patients.
Clin Pharmacokinet. 1988 Jan;14(1):52-63. doi: 10.2165/00003088-198814010-00004.
8
Kinetics of intravenous metoclopramide in patients with hepatic cirrhosis.
Eur J Clin Pharmacol. 1991;40(4):423-5. doi: 10.1007/BF00265857.
9
Pharmacokinetics of metoclopramide in patients with liver cirrhosis.肝硬化患者中甲氧氯普胺的药代动力学
Br J Clin Pharmacol. 1991 Feb;31(2):185-7. doi: 10.1111/j.1365-2125.1991.tb05511.x.

本文引用的文献

3
Lidocaine plasma protein binding.利多卡因的血浆蛋白结合
Clin Pharmacol Ther. 1980 Mar;27(3):347-51. doi: 10.1038/clpt.1980.46.
6
Drug therapy in renal failure.
Annu Rev Pharmacol Toxicol. 1980;20:45-54. doi: 10.1146/annurev.pa.20.040180.000401.
7
Determinants of the plasma protein binding of theophylline in health.健康状态下茶碱血浆蛋白结合的决定因素。
Br J Clin Pharmacol. 1983 Apr;15(4):399-405. doi: 10.1111/j.1365-2125.1983.tb01521.x.
8
Disease-induced changes in the plasma binding of basic drugs.疾病引起的碱性药物血浆结合变化。
Clin Pharmacokinet. 1980 May-Jun;5(3):246-62. doi: 10.2165/00003088-198005030-00004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验